PDCD1 and neoplasm: The anti-PD-L1 antibody has shown antitumor response in cancer patients with high levels of PD-L1 expression on tumor-infiltrating immune cells, and with some difference in results, a high expression of PD-1 has been observed in CTCL too (82, 104, 105).